RepliCel Life Sciences's total assets for Q3 2025 were C$13.66K, a decrease of -38.81% from the previous quarter. REPCF total liabilities were C$1.22M for the fiscal quarter, a 1.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.